These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35059746)

  • 21. Establishment of a cell culture platform for human liver organoids and its application for lipid metabolism research.
    Kuboyama-Sasaki A; Takahashi Y; Xia C; Hiro K; Kobayashi T; Ohdan H; Shimizu M; Yamauchi Y; Kiyono H; Sato R
    Biotechnol J; 2024 Jan; 19(1):e2300365. PubMed ID: 37920068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creating rat hepatocyte organoid as an
    He YT; Zhu XL; Li SF; Zhang BQ; Li Y; Wu Q; Zhang YL; Zhou YY; Li L; Qi YN; Bao J; Bu H
    World J Stem Cells; 2020 Oct; 12(10):1184-1195. PubMed ID: 33178400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment and Genetic Manipulation of Murine Hepatocyte Organoids.
    Lian J; Meng X; Zhang X; Hu H
    J Vis Exp; 2022 Feb; (180):. PubMed ID: 35225254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line.
    Green CJ; Johnson D; Amin HD; Sivathondan P; Silva MA; Wang LM; Stevanato L; McNeil CA; Miljan EA; Sinden JD; Morten KJ; Hodson L
    Am J Physiol Endocrinol Metab; 2015 Sep; 309(6):E511-22. PubMed ID: 26126685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research progress and application of liver organoids for disease modeling and regenerative therapy.
    Hu Y; Geng Q; Wang L; Wang Y; Huang C; Fan Z; Kong D
    J Mol Med (Berl); 2024 Jul; 102(7):859-874. PubMed ID: 38802517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function.
    Yu HM; Chung HK; Park KS
    Biochem Biophys Res Commun; 2021 Jun; 558():57-63. PubMed ID: 33895552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease.
    Breher-Esch S; Sahini N; Trincone A; Wallstab C; Borlak J
    BMC Med Genomics; 2018 Dec; 11(1):111. PubMed ID: 30547786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping of mitogen and metabolic sensitivity in organoids defines requirements for human hepatocyte growth.
    Hendriks D; Artegiani B; Margaritis T; Zoutendijk I; Chuva de Sousa Lopes S; Clevers H
    Nat Commun; 2024 May; 15(1):4034. PubMed ID: 38740814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia.
    Chusilp S; Lee C; Li B; Lee D; Yamoto M; Ganji N; Vejchapipat P; Pierro A
    Pediatr Surg Int; 2020 Dec; 36(12):1471-1479. PubMed ID: 33084932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison between different human hepatocyte models reveals profound differences in net glucose production, lipid composition and metabolism in vitro.
    Bonanini F; Singh M; Yang H; Kurek D; Harms AC; Mardinoglu A; Hankemeier T
    Exp Cell Res; 2024 Apr; 437(1):114008. PubMed ID: 38499143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene manipulation in liver ductal organoids by optimized recombinant adeno-associated virus vectors.
    Wei J; Ran G; Wang X; Jiang N; Liang J; Lin X; Ling C; Zhao B
    J Biol Chem; 2019 Sep; 294(38):14096-14104. PubMed ID: 31366731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organoids to model liver disease.
    Nuciforo S; Heim MH
    JHEP Rep; 2021 Feb; 3(1):100198. PubMed ID: 33241206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Culture and establishment of self-renewing human liver 3D organoids with high uric acid for screening antihyperuricemic functional compounds.
    Hou C; Sha W; Xu Z; Hu Y; Amakye WK; Yao M; Ren J
    Food Chem; 2022 Apr; 374():131634. PubMed ID: 34838408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
    Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
    Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids.
    Mun SJ; Lee J; Chung KS; Son MY; Son MJ
    Cells; 2021 Jan; 10(1):. PubMed ID: 33440728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of choline on hepatic lipid metabolism, mitochondrial function and antioxidative status in human hepatic C3A cells exposed to excessive energy substrates.
    Zhu J; Wu Y; Tang Q; Leng Y; Cai W
    Nutrients; 2014 Jul; 6(7):2552-71. PubMed ID: 25010553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.
    Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential and limitations of intrahepatic cholangiocyte organoids to study inborn errors of metabolism.
    Lehmann V; Schene IF; Ardisasmita AI; Liv N; Veenendaal T; Klumperman J; van der Doef HPJ; Verkade HJ; Verstegen MMA; van der Laan LJW; Jans JJM; Verhoeven-Duif NM; van Hasselt PM; Nieuwenhuis EES; Spee B; Fuchs SA
    J Inherit Metab Dis; 2022 Mar; 45(2):353-365. PubMed ID: 34671987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
    Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
    Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human induced pluripotent stem cells-derived liver organoids grown on a Biomimesys® hyaluronic acid-based hydroscaffold as a new model for studying human lipoprotein metabolism.
    Roudaut M; Caillaud A; Souguir Z; Bray L; Girardeau A; Rimbert A; Croyal M; Lambert G; Patitucci M; Delpouve G; Vandenhaute É; Le May C; Maubon N; Cariou B; Si-Tayeb K
    Bioeng Transl Med; 2024 Jul; 9(4):e10659. PubMed ID: 39036087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.